LSE:SKP

Mundipharma Appointed as Development and Marketing Partner for flutiform(R) in Mexico, Central and South America

SINGAPORE, Jan. 28, 2016 /PRNewswire/ -- Mundipharma International Corporation Limited has announced that it has entered into agreements with Skyepharma PLC (LSE SKP), the expert oral and inhalation drug development company, and Sanofi Winthrop Industrie ("Sanofi") to transfer the exclusive devel...

2016-01-28 15:26 2578

Week's Top Stories